Advertisement

Topics

Xavant's noninvasive neuromodulation device wins FDA clearance

06:21 EDT 2 Aug 2017 | SmartBrief

Xavant Technology obtained FDA clearance for its Stimpod NMS460, a noninvasive neuromodulation device designed for symptomati -More

Original Article: Xavant's noninvasive neuromodulation device wins FDA clearance

NEXT ARTICLE

More From BioPortfolio on "Xavant's noninvasive neuromodulation device wins FDA clearance"

Quick Search
Advertisement